It’s just not fair. One measly gene — out of more than 20,000 — goes wrong, and a newborn baby faces a future with a disease that could hamper her mobility, make breathing a struggle or even end her life.
New research led by Jennifer Trowbridge provides insight into risk factors for clonal hematopoiesis-to-leukemia progression.
Mutations in our genes can cause life-threatening diseases, and sometimes there is no drug or surgery available for your doctor to prescribe. Enter gene therapy.
Do you know what genetics is? How about genomics? What's the difference between the two?
Using computer models, researchers have identified a potential new therapy that would reduce the long-term side effects of radiation therapy in pediatric brain cancer patients.
JAX-CKB is a powerful tool for interpreting complex genomic profiles, and represents a valuable resource for clinicians and translational and clinical researchers. JAX-CKB advances JAX’s mission to discover genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
JAX’s Stitzel Laboratory secures funding from the National Institute of Diabetes and Digestive and Kidney Diseases that will allow them to explore a new genomic region linked to type 2 diabetes, with hopes of establishing them as new targets for treatment.
JAX researcher Ron Korstanje is closer to understanding exactly how bear kidneys recover from the damage caused by hibernation.
A team led by JAX researcher Mauro Costa, Ph.D. has uncovered potential links between genetic heart defects and metabolism in adults. Their findings could be the first steps toward treatments to prevent the progression of heart failure.
JAX-CKB is a powerful tool for interpreting complex genomic profiles and represents a valuable resource for clinicians and translational and clinical researchers.